The Translational Science Benefits Model (TSBM), created by the Institute of Clinical and Translational Sciences at Washington University in St. Louis, is a framework public health and clinical scientists use to demonstrate the impact of their work in the real world. First published September 8, 2017 in Clinical and Translational Science, TSBM was inspired by the desire to look beyond simple number counts of scientific productivity and visibility to identify broader measures of “real world” benefits in four distinct domains: clinical, community, economic, and policy.
Researchers at Oregon Clinical and Translational Research Institute have recently utilized the TSBM to measure the impact of their work with two research projects, “SOLACE: An Early Warning System for Adolescent Suicidality” and “Reducing Diabetes Risk Factors”.